Companies: 10,795·Total market cap: $144.5T
SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc.

SLSNASDAQHealthcare● Active
$7.98
$-0.25(-3.04%)
Market Cap$1.1B
P/E Ratio
52W High$9.51
52W Low$1.39

SELLAS Life Sciences Group, Inc. (SLS) Stock Ownership

Latest 13F position summary is not yet available — breakdown and tables fill in after filings publish (typically ~45 days after quarter end).

SEC 13F · FMP · SLS · as of —

Ownership Breakdown

Institutional data for this period is not yet available. SEC Form 13F filings are typically published 45 days after quarter end.

No institutional data available for this period.

Insider Buying vs Selling

SLS insider trading · insider activity

Source: SEC Form 4

Recent Insider Transactions

Showing 10 most recent · Common Stock only

No recent insider transactions reported.

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

SELLAS Life Sciences Group, Inc. (SLS) is primarily owned by institutional investors, who hold approximately — of total shares outstanding. Company insiders own approximately —, while retail and public investors account for the remaining —.

A total of 0 institutional investors currently hold SLS stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.

Frequently asked questions

SLS ownership

SELLAS Life Sciences Group, Inc. (SLS) is primarily owned by institutional investors, who hold approximately — of shares. The largest shareholder is — with a — stake. Company insiders hold —. Data sourced from SEC Form 13F as of —.

who owns SLS stockSLS ownership structureSEC Form 13F institutional holdingsSLS float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of